Q1 FY27 Earnings

LargestFastest profit growthFastest sales growthBiggest beatsBiggest misses

Sector All sectorsAerospace & DefenseAutomobilesAviationBanksBeveragesCablesCapital GoodsCapital MarketsCastings, Forgings & FastnersChemicalsCommercial ServicesCommoditiesConstructionConsumer DiscretionaryConsumer DurablesConsumer GoodsConsumer ServicesDiamond, Gems and JewelleryDiversifiedEducationEnergyEngineering ServicesFast Moving Consumer GoodsFinancial ServicesFMCGFood ProductsForest MaterialsHealthcareHealthcare ServicesIndustrial ProductsIndustrialsInformation TechnologyInsuranceLeisure ServicesLogistics & CargoMediaMetals & MiningOil & GasPackagingPetroleum ProductsPowerPrinting & StationeryRealtyRetailServicesSteelTelecomTelecommunicationTextilesTradingTransportTransport ServicesUtilities Result Any resultBeatMissedIn lineNo estimate Clear filters 1–14 of 14

Company		Revenue (₹ Cr)			Profit (₹ Cr)		Per share		8Q profit
Symbol	Sector	Reported ↓	YoY	QoQ	Reported	YoY	EPS	vs consensus	Trend
AUROPHARMA Aurobindo Pharma Ltd	Healthcare	9,150	up+16.3%	up+3.4%	1,032	up+25.2%	17.95	Beat +5.8% est. 16.88
LUPIN Lupin Ltd	Healthcare	8,277	up+32.0%	up+10.7%	1,417	up+16.1%	30.95	Beat +5.6% est. 29.31
MANKIND Mankind Pharma Ltd	Healthcare	4,031	up+12.9%	up+17.1%	574	up+29.0%	13.75	Beat +3.8% est. 13.26
DIVISLAB Divis Laboratories Ltd	Healthcare	3,080	up+27.8%	up+8.8%	902	up+65.5%	33.98	Beat +41.4% est. 24.01
IPCALAB Ipca Laboratories Ltd	Healthcare	2,788	up+20.7%	up+16.8%	424	up+82.1%	15.84	Beat +42.7% est. 11.10
PPLPHARMA Piramal Pharma Ltd	Healthcare	2,270	up+17.4%	down-17.5%	-69	n/a	-0.52	Beat +36.2% est. -0.82
APLLTD Alembic Pharmaceuticals Ltd	Healthcare	2,150	up+25.6%	up+16.3%	172	up+11.9%	8.80	Beat +17.3% est. 7.50
LAURUSLABS Laurus Labs Ltd	Healthcare	2,026	up+29.0%	up+11.8%	362	up+123.5%	6.80	Beat +52.7% est. 4.46
GLAND Gland Pharma Ltd	Healthcare	1,800	up+19.5%	up+3.3%	317	up+47.4%	19.21	Beat +10.0% est. 17.49
AJANTPHARM Ajanta Pharma Ltd	Healthcare	1,626	up+24.8%	up+14.3%	334	up+31.0%	26.75	Beat +16.3% est. 23.00
INDGN Indegene Ltd	Healthcare	1,063	up+39.7%	up+6.0%	116	0.0%	4.82	Beat +3.0% est. 4.70
NEULANDLAB Neuland Laboratories Ltd	Healthcare	642	up+119.0%	down-17.3%	148	up+954.8%	115.10	Beat +91.8% est. 60.01
POLYMED Poly Medicure Ltd	Healthcare	525	up+30.4%	down-1.8%	85	down-8.3%	8.49	Beat +30.6% est. 6.50
COHANCE Cohance Lifesciences Ltd	Healthcare	422	down-23.1%	down-31.8%	-45	down-198.2%	-0.63	Beat +10.0% est. -0.70

About Q1 FY27 earnings data

When are Q1 FY27 results announced?

Q1 FY27 covers the Apr–Jun 2026 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.

How many companies have declared Q1 FY27 results so far?

1,543 of 1,560 companies expected to report this quarter have filed. The rest are still to come; the count updates as filings land.

Why do some Q1 FY27 growth figures show "n/a" instead of a percentage?

Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.

Does the beat/miss verdict cover every company?

No, and the denominator matters. An analyst consensus existed for 354 of the 4,695 companies that reported Q1 FY27 — 7.5%. Beat, missed and in-line describe only those. Every other company is marked "no estimate" rather than being counted as in line, because nobody forecast it. Revenue and profit growth, by contrast, cover every company in the table.

What counts as an in-line result rather than a beat or a miss?

Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.

Are the figures consolidated or standalone?

Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.

What does the 8-quarter trend line show?

Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.

How do I find only the companies that beat estimates in Q1 FY27?

Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.